Alemtuzumab (CAMPATH 1H) does not kill chronic lymphocytic leukemia cells in serum free medium

Clive S. Zent(University of Rochester Medical Center), Steven A. Schichman(Central Arkansas Veterans Healthcare System), H. Marie Lacy(University of Arkansas for Medical Sciences), Richard C. Kurten(University of Arkansas for Medical Sciences), James B. Chen(University of Arkansas for Medical Sciences), Gur P. Kaushal(University of Arkansas for Medical Sciences)
Leukemia Research
December 13, 2003
10.1016/j.leukres.2003.09.011
Cited by 60

Related Papers

Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder
|JAMA|2022|195
High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions
|Blood|2001|188
p53-dependent Caspase-2 Activation in Mitochondrial Release of Apoptosis-inducing Factor and Its Role in Renal Tubular Epithelial Cell Injury
|Journal of Biological Chemistry|2005|172
Accelerated DNA methylation age: Associations with PTSD and neural integrity
|Psychoneuroendocrinology|2015|152
Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data
|Cancer|2001|118